News
In a groundbreaking scientific achievement, Colossal Biosciences, a biotechnology and genetic engineering company, has ...
Mites are common in the Antarctic – there are hundreds of species. Some even live in the nasal cavities of penguins. Penguin ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
Inscripta are pleased to announce a strategic partnership in the beauty industry. This science-driven collaboration, goes ...
Could it be that one of only three known markers directly targeting the DNA does not exist outside the realm of microbes? Now ...
1d
Clinical Trials Arena on MSNFDA to phase out animal testing with AI and lab-based modelsThe FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
Overview of the In-Vitro Toxicology Testing Market. The global in-vitro toxicology testing market is on a steady growth trajectory, with a valuation of US$ 24.18 billion in 2023.
Elanco recently announced a research agreement to treat chronic kidney disease (CKD) in cats and investigate approaches to ...
D. T. Max on the startup reversing extinction. Plus: how Trump crushed the stock market; and Seth Rogen’s notes on Hollywood.
US-based biotech firm Colossal Laboratories announced Tuesday that it has 'brought back' the extinct dire wolf species using ...
However, GOT fans still haven’t forgiven Jon Snow (Kit Harrington) for ghosting his beloved Ghost. In the bloody Battle of ...
With a projected CAGR of 6.79% from 2024 to 2032, the global small animal imaging market is expected to see a significant rise in demand, leading to substantial improvements in research capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results